🇺🇸 FDA
Patent

US 10441614

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

granted A61KA61K35/763A61K38/1748

Quick answer

US patent 10441614 (Compositions and methods for the treatment of wounds, disorders, and diseases of the skin) held by Krystal Biotech, Inc. expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Krystal Biotech, Inc.
Grant date
Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K35/763, A61K38/1748, A61K38/39, A61K47/38